Our company is a Canadian-based biomedical technology firm specializing in the development of advanced processing solutions for biological tissues, specifically allografts (tissue donated from cadavers in hospitals and processed using tissue engineering techniques for use in approximately 52 types of surgeries). Our core business involves research, development, validation, preclinical assessment, and commercialization of proprietary media and buffers designed to enhance the performance and safety of regenerative medicine products, such as bone allografts in orthopedic and dental applications.

Our primary product is AlloWide Buffer, a novel proprietary solution designed for the rehydration and preparation of bone allografts. It is formulated as a superior alternative to traditional normal saline, with the specific goal of improving the handling characteristics, biological activity, and ultimately the clinical outcomes of the bone graft material at the point of care.